Mirko Bouda
Pilsen, PL, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 27, 2022
BK polyomavirus and valganciclovir: Highly suspected association urgently calling for a new randomized trial.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: September 19, 2019
Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 07, 2019
Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: December 02, 2018
Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial.
Journal: BMC infectious diseases
Published: March 06, 2018
The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation.
Journal: Antiviral therapy
Published: January 09, 2017
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: November 27, 2014
Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: November 16, 2014
Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 25, 2012
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients.
Journal: Antiviral therapy
Published: December 14, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026